Targeting Enhancer of Zeste Homolog 2 (Ezh2) in Soft Tissue Sarcoma to Enhance Immunogenicity and the Efficacy of Immune Checkpoint Inhibitors( III )

2023-08-012024-05-17https://scholars.lib.ntu.edu.tw/handle/123456789/683337Targeting Enhancer of Zeste Homolog 2 (Ezh2) in Soft Tissue Sarcoma to Enhance Immunogenicity and the Efficacy of Immune Checkpoint Inhibitors( III )